Advice on the morning-after pill: how often can you take it?

Emergency contraception — commonly referred to as the “morning-after pill” — is an important option for preventing unintended pregnancy after unprotected intercourse, contraceptive failure, or sexual assault. Because there are many questions about how it works, how often it can be used, and what side effects to expect, this article reviews current clinical guidance on emergency contraceptive methods, efficacy, safety, timing, interactions, and practical counseling points. Information is presented for health education purposes and cites major clinical sources (ACOG, NIH/MedlinePlus, Mayo Clinic, Cleveland Clinic).

Overview: what is emergency contraception?

Emergency contraception (EC) refers to methods used to prevent pregnancy after intercourse when regular contraceptive methods were not used correctly or at all. EC is intended for occasional use and is not a primary form of ongoing contraception.

Common forms of emergency contraception include:

  • Levonorgestrel oral pill (1.5 mg single dose; over-the-counter in many countries; brand names include Plan B One-Step and generics).
  • Ulipristal acetate oral pill (30 mg single dose; prescription in some regions; brand name ella).
  • Copper intrauterine device (IUD; non-hormonal; can be inserted within 5 days of ovulation or within 5 days of intercourse depending on guidance; the most effective EC option).

Clinical organizations emphasize selecting the method most appropriate for the patient’s timing, medical history, and preferences (ACOG; Mayo Clinic).

How emergency contraceptives work

Understanding the mechanism of action helps clarify common misconceptions:

  • Levonorgestrel and ulipristal primarily act by preventing or delaying ovulation — that is, they interfere with the process by which an egg is released from the ovary. If ovulation has already occurred, these pills are much less likely to be effective.
  • The copper IUD primarily prevents fertilization by creating a local environment that is toxic to sperm and may also inhibit implantation; it does not terminate an established pregnancy.

Major professional bodies such as the American College of Obstetricians and Gynecologists (ACOG) and the World Health Organization state that emergency contraception does not terminate an existing pregnancy (ACOG; NIH/MedlinePlus).

Timing and effectiveness

Time from intercourse to administration is the single most important determinant of EC effectiveness.

  • Levonorgestrel: most effective when taken as soon as possible and within 72 hours (3 days) after unprotected intercourse. Efficacy declines with time but may provide some effect up to 72 hours (ACOG; Mayo Clinic).
  • Ulipristal acetate: effective up to 120 hours (5 days) after intercourse and is generally more effective than levonorgestrel for the 0–120 hour window, especially when intercourse is closer to ovulation (ACOG; NIH).
  • Copper IUD: can be inserted up to at least 5 days after ovulation or within 5 days after unprotected intercourse depending on local guidance, and is the most effective emergency contraceptive available. It also provides ongoing contraception for years if the patient desires (ACOG; Cleveland Clinic).

No oral EC pill guarantees pregnancy prevention; effectiveness varies with timing, body weight, and whether ovulation has already occurred.

How often can you take the morning-after pill?

This is one of the most commonly asked clinical questions. Key points:

  • There is no absolute medical limit on the number of times a person can take emergency contraceptive pills over a lifetime. Short-term repeated use has not been shown to cause long-term health harm (ACOG).
  • However, EC pills are intended for occasional emergency use and are not as effective as routine, ongoing contraceptive methods. Repeated reliance on EC for routine contraception is associated with higher pregnancy risk compared with consistent use of a regular contraceptive method (e.g., oral contraceptives, intrauterine devices, implants).
  • Repeated doses may increase the likelihood of menstrual irregularities (temporary changes in cycle timing or bleeding pattern) and transient side effects such as nausea or fatigue, but serious adverse events are uncommon (Mayo Clinic; Cleveland Clinic).
  • For people who find themselves using EC frequently, counseling about and initiation of an appropriate ongoing contraceptive method is recommended to improve pregnancy prevention and reduce the need for emergency methods (ACOG; NIH).

In short: you can take the morning-after pill more than once if needed, but it should not be relied upon as your primary method of contraception. Discuss alternatives with a clinician if you require EC frequently.

Safety profile and common side effects

Emergency contraceptive pills are generally well tolerated. Common side effects include:

  • Nausea or vomiting
  • Abdominal pain or cramping
  • Fatigue
  • Headache
  • Dizziness
  • Breast tenderness
  • Spotting or changes in the timing of the next menstrual period

These effects are usually transient and resolve without specific treatment. If vomiting occurs within two hours of taking an oral EC pill, the dose may not have been fully absorbed; retaking the dose or considering a different method (clinic evaluation and possible IUD) is recommended (Mayo Clinic; ACOG).

Serious complications are rare. EC pills do not increase the risk of future infertility and are not associated with long-term adverse outcomes when used appropriately (ACOG).

Impact on the menstrual cycle: when will your period arrive?

After taking emergency contraception, menstrual timing can be affected:

  • Levonorgestrel: may cause the next period to occur earlier or later than expected. Most periods return to normal in the next cycle, but some people experience a delay of a few days to a week.
  • Ulipristal acetate: may cause a slightly longer delay in the next period compared with levonorgestrel. If menses are delayed by more than 7 days after the expected date, pregnancy testing is advised.
  • Copper IUD: because it does not add hormones, it generally does not change the timing of the next period beyond the usual variation for the person; however, the IUD can cause heavier menstrual bleeding and increased cramping for some users.

If the period is more than 7–14 days late after taking EC, the patient should perform a pregnancy test and seek clinical evaluation (ACOG; Mayo Clinic).

Special considerations

Body weight and BMI

  • Evidence suggests that levonorgestrel emergency contraception may be less effective in people with higher body mass index (BMI), particularly at BMI ≥ 30 kg/m². Ulipristal may also have reduced effectiveness at higher BMIs, although data are mixed (ACOG; NIH).
  • Because of potential decreased effectiveness of oral EC in higher BMI ranges, healthcare providers should discuss the copper IUD as a preferred option for emergency contraception in people with higher body weight, when available and acceptable (ACOG; Cleveland Clinic).

Drug interactions and enzyme inducers

  • Certain medications and herbal supplements that induce liver enzymes (e.g., rifampin, carbamazepine, phenytoin, phenobarbital, St. John's wort) can decrease the effectiveness of levonorgestrel and ulipristal by accelerating metabolism.
  • If a patient is taking or has recently taken enzyme-inducing medications, the copper IUD is the most reliable emergency option. If an IUD is not acceptable or available, healthcare providers should consider options and may recommend repeat dosing or alternative methods based on clinical judgment (ACOG; NIH).

Breastfeeding

  • Levonorgestrel: considered compatible with breastfeeding. Some guidance recommends breastfeeding may continue after administration of levonorgestrel; minimal amounts are excreted in breast milk and are not expected to affect the infant (Mayo Clinic; NIH).
  • Ulipristal acetate: limited data; professional guidance generally advises against breastfeeding for one week after taking ulipristal and recommends discarding breast milk pumped during that time (ACOG; EMA labeling). Patients should discuss breastfeeding plans with their clinician if ulipristal is being considered.

Adolescents

  • Emergency contraception is safe for adolescents. In many regions, levonorgestrel is available over the counter without age restriction; ulipristal may require prescription. Confidentiality, counseling, and consideration of ongoing contraception are important in adolescent care (ACOG).

Interactions with ongoing hormonal contraception

How to start or resume regular hormonal contraception after EC depends on the EC used:

  • After levonorgestrel: hormonal contraception (combined oral contraceptives, patches, rings, progestin-only pills, or long-acting methods) can generally be started immediately after taking levonorgestrel. Use backup contraception (e.g., condoms) for 7 days if starting a hormonal method that requires a week to become fully effective, depending on the specific method (ACOG).
  • After ulipristal acetate: patients should avoid initiating or resuming hormonal methods containing progestins for at least 5 days after taking ulipristal because progestin exposure may reduce ulipristal effectiveness. Use barrier methods or abstinence for those 5 days, and until the next menstrual period if advised by the clinician (ACOG; NIH).
  • If a copper IUD is inserted for EC, it simultaneously provides effective ongoing contraception and does not require a waiting period for other methods.

Always review a patient’s specific contraception plan and provide clear instructions about when to use additional protection.

Vomiting after taking emergency contraception

  • If vomiting occurs within two hours after taking a levonorgestrel or ulipristal pill, the medication may not have been absorbed sufficiently. The usual recommendation is to repeat the dose if vomiting occurs within two hours, and to contact a healthcare provider for guidance. An IUD can be considered as an alternative if vomiting prevents oral therapy (Mayo Clinic; ACOG).

Pregnancy testing and follow-up

  • If the period is delayed by more than 7–14 days after using EC, or if there are signs or symptoms suggestive of pregnancy (persistent nausea, breast enlargement, excessive fatigue), the patient should perform a pregnancy test and seek clinical follow-up.
  • Emergency contraception is not intended to be used to terminate an established pregnancy. If pregnancy is confirmed after EC, management should follow standard obstetric counseling and care (ACOG; NIH).

Copper IUD as the most effective option

When counseling patients about emergency contraception, it is important to present the copper IUD as the most effective option:

  • The copper IUD inserted within the appropriate time window provides the highest effectiveness for emergency contraception and also offers immediate and long-term contraception (up to 10–12 years depending on device) if the patient desires ongoing protection (ACOG; Cleveland Clinic).
  • Barriers to IUD use may include access, cost, and patient preference. If a patient prefers pills, discuss comparative effectiveness and any patient-specific considerations (e.g., BMI, medications).

Myths and clarifications

  • EC is not the same as medication abortion. Emergency contraception prevents or delays ovulation and does not terminate an existing intrauterine pregnancy (ACOG; NIH).
  • EC does not protect against sexually transmitted infections (STIs). Patients with potential STI exposure should be offered testing and counseling as appropriate.
  • EC is safe for most people and does not cause infertility.
  • Using EC occasionally does not require special medical tests in most cases, but repeated use should prompt discussion about a regular contraceptive strategy.

Practical counseling points for clinicians

  • Emphasize that the sooner EC is taken after unprotected intercourse, the more effective it is.
  • Discuss method choice: levonorgestrel (OTC; within 72 hours), ulipristal (prescription; up to 120 hours and typically more effective than levonorgestrel), and copper IUD (most effective; up to 5 days or per clinic protocol).
  • Ask about medication use (enzyme inducers), breastfeeding, and body weight/BMI to tailor recommendations.
  • Provide instructions about what to do if vomiting occurs and when to repeat dosing or seek clinic care.
  • When appropriate, initiate counseling about ongoing contraceptive options and assist with prompt access to long-acting reversible contraception (IUD or implant) if desired.
  • Ensure confidentiality and address cost and access barriers where possible.

When to seek immediate medical attention

Seek urgent medical care if the patient experiences:

  • Severe abdominal pain after an IUD insertion (possible complications).
  • Signs of anaphylaxis or severe allergic reaction after taking medication (very rare).
  • Persistent vomiting preventing absorption of oral EC and inability to receive an IUD.
  • Any other concerning symptoms as advised by a clinician.

Summary: practical takeaways

  • Emergency contraception is safe and effective when used appropriately. It should be used as an occasional backup method and not as the primary method of contraception.
  • There is no strict medical limit to the number of times a person can take EC pills; however, frequent use is not recommended because longer-term contraceptive methods are more effective for preventing pregnancy.
  • The copper IUD is the most effective emergency contraceptive and is preferable for those who need reliable EC and desire ongoing contraception.
  • Levonorgestrel is available over the counter and is effective within 72 hours; ulipristal is effective up to 120 hours and may be more effective near ovulation.
  • Discuss BMI, medications, and breastfeeding status when selecting an EC method; consider copper IUD for people with higher BMI or those taking enzyme-inducing drugs.
  • If periods are delayed beyond 7–14 days after EC, perform a pregnancy test and seek clinical follow-up.

If you have repeated need for emergency contraception or have concerns about choosing the most appropriate method, consult with a gynecologist, primary care clinician, or local family planning clinic for individualized counseling and access to ongoing contraceptive options.

References and resources

  • American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin and Committee Opinions on Emergency Contraception. ACOG patient FAQs and clinical guidance on contraception and emergency contraception. (ACOG.org)
  • National Institutes of Health / MedlinePlus. Emergency Contraception. Overview of methods, safety, and use. (MedlinePlus/NLM)
  • Mayo Clinic. Emergency contraception: How it works and where to get it. (MayoClinic.org)
  • Cleveland Clinic. Emergency contraception: types, how it works, and when to seek help. (ClevelandClinic.org)

(For detailed, up-to-date clinical guidance, consult the cited organizations’ official publications and local clinical protocols.)